The genes c-MET, ARID1A, CTNNB1 and RAF1 showing an association with the proliferative subtype in our study may be used as molecular markers for subtype determination, and hub genes can be applied for HCC diagnosis. This evidence concerns the gene ARID1A and hepatocellular carcinoma.